These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22434686)

  • 1. Teratogen update: methotrexate.
    Hyoun SC; Običan SG; Scialli AR
    Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental delay in fetal aminopterin/methotrexate syndrome.
    Del Campo M; Kosaki K; Bennett FC; Jones KL
    Teratology; 1999 Jul; 60(1):10-2. PubMed ID: 10413333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy.
    Poggi SH; Ghidini A
    Fertil Steril; 2011 Sep; 96(3):669-71. PubMed ID: 21733506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult and two children with fetal methotrexate syndrome.
    Bawle EV; Conard JV; Weiss L
    Teratology; 1998 Feb; 57(2):51-5. PubMed ID: 9562676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?
    Enns GM; Roeder E; Chan RT; Ali-Khan Catts Z; Cox VA; Golabi M
    Am J Med Genet; 1999 Sep; 86(3):237-41. PubMed ID: 10482872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methotrexate during pregnancy: risk of malformations.
    Prescrire Int; 2010 Oct; 19(109):212-3. PubMed ID: 21180376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy and teratogenicity.
    Paskulin GA; Gazzola Zen PR; de Camargo Pinto LL; Rosa R; Graziadio C
    Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):634-7. PubMed ID: 16104005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal methotrexate syndrome: A systematic review of case reports.
    Verberne EA; de Haan E; van Tintelen JP; Lindhout D; van Haelst MM
    Reprod Toxicol; 2019 Aug; 87():125-139. PubMed ID: 31181251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?
    Piggott KD; Sorbello A; Riddle E; DeCampli W
    Pediatr Cardiol; 2011 Apr; 32(4):518-20. PubMed ID: 21327892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrada of the possible mycophenolate mofetil embryopathy: a review.
    Merlob P; Stahl B; Klinger G
    Reprod Toxicol; 2009 Jul; 28(1):105-8. PubMed ID: 19491002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septo-optic dysplasia as a manifestation of valproic acid embryopathy.
    McMahon CL; Braddock SR
    Teratology; 2001 Aug; 64(2):83-6. PubMed ID: 11460259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic.
    Nurmohamed L; Moretti ME; Schechter T; Einarson A; Johnson D; Lavigne SV; Erebara A; Koren G; Finkelstein Y
    Am J Obstet Gynecol; 2011 Dec; 205(6):533.e1-3. PubMed ID: 21907957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fetal aminopterin syndrome].
    Harada M
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):88-9. PubMed ID: 11057154
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies.
    Sloot WN; Bowden HC; Yih TD
    Reprod Toxicol; 2009 Sep; 28(2):270-82. PubMed ID: 19383541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the antifolate drug Methotrexate on the development of murine neural tube defects and genomic instability.
    Zhao J; Guan T; Wang J; Xiang Q; Wang M; Wang X; Guan Z; Xie Q; Niu B; Zhang T
    J Appl Toxicol; 2013 Sep; 33(9):915-23. PubMed ID: 22806879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal methotrexate and misoprostol exposure: the past revisited.
    Wheeler M; O'Meara P; Stanford M
    Teratology; 2002 Aug; 66(2):73-6. PubMed ID: 12210010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations.
    Kozma C; Ramasethu J
    Am J Med Genet A; 2011 Jul; 155A(7):1723-8. PubMed ID: 21671374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy outcome after preconceptional exposure to methotrexate for ectopic pregnancy].
    Lagarce L; Bernard N; Carlier P; Phelipot-Lates S; Perault-Pochat MC; Drablier G; Bourneau-Martin D; Lainé-Cessac P;
    Therapie; 2016 Sep; 71(4):389-94. PubMed ID: 27203166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.